{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:14:15Z","timestamp":1770452055105,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,21]]},"DOI":"10.7759\/cureus.92853","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:35:49Z","timestamp":1758472549000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Antidiabetic Medication Regimens and Medication Adherence With HbA1c Reduction in Type 2 Diabetic Patients: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Naveen","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najma","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Junaid","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorez Rashid","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haris","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Azzem","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12092110","article-title":"The impact of medication regimen adjustment ratio on adherence and glycemic control in patients with type 2 diabetes and mild cognitive impairment","volume":"12","author":"Song X","year":"2024","unstructured":"Song X, Wu J, Yang Y, et al.. The impact of medication regimen adjustment ratio on adherence and glycemic control in patients with type 2 diabetes and mild cognitive impairment. Biomedicines. 2024, 12:2110. 10.3390\/biomedicines12092110","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12430","article-title":"Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)","volume":"7","author":"Kanatsuka A","year":"2016","unstructured":"Kanatsuka A, Sato Y, Kawai K, et al.. Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38). J Diabetes Investig. 2016, 7:386-95. 10.1111\/jdi.12430","journal-title":"J Diabetes Investig"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028823","article-title":"Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study","volume":"101","author":"Lee KA","year":"2022","unstructured":"Lee KA, Jin HY, Kim YJ, Kim SS, Cho EH, Park TS. Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study. Medicine (Baltimore). 2022, 101:e28823. 10.1097\/MD.0000000000028823","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077097","article-title":"Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: Emulation of a target trial using routinely collected health data","volume":"385","author":"Bidulka P","year":"2024","unstructured":"Bidulka P, Lugo-Palacios DG, Carroll O, et al.. Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: Emulation of a target trial using routinely collected health data. BMJ. 2024, 385:e077097. 10.1136\/bmj-2023-077097","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2016.1157263","article-title":"Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: A retrospective cohort study","volume":"48","author":"Mamza J","year":"2016","unstructured":"Mamza J, Mehta R, Donnelly R, Idris I. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: A retrospective cohort study. Ann Med. 2016, 48:224-34. 10.3109\/07853890.2016.1157263","journal-title":"Ann Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-45","article-title":"Therapies for type 2 diabetes: Lowering HbA1c and associated cardiovascular risk factors","volume":"9","author":"Kurukulasuriya LR","year":"2010","unstructured":"Kurukulasuriya LR, Sowers JR. Therapies for type 2 diabetes: Lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol. 2010, 9:45. 10.1186\/1475-2840-9-45","journal-title":"Cardiovasc Diabetol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-66468-1","article-title":"Oral antidiabetic therapy versus early insulinization on glycemic control in newly diagnosed type 2 diabetes patients: A retrospective matched cohort study","volume":"14","author":"Lee YM","year":"2024","unstructured":"Lee YM, Lin PR, Sia HK. Oral antidiabetic therapy versus early insulinization on glycemic control in newly diagnosed type 2 diabetes patients: A retrospective matched cohort study. Sci Rep. 2024, 14:15491. 10.1038\/s41598-024-66468-1","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.70749\/ijbr.v2i02.152","article-title":"Evaluating the iron deficiency anemia in type-II diabetic patients taking metformin and its association with oxidative stress","volume":"2","author":"Umer A","year":"2024","unstructured":"Umer A, Sarfraz J, Ahmed H, Qayyum RA, Parveen A, Manan Z, Qammar B. Evaluating the iron deficiency anemia in type-II diabetic patients taking metformin and its association with oxidative stress. Indus J Biosci Res. 2024, 2:178-82. 10.70749\/ijbr.v2i02.152","journal-title":"Indus J Biosci Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-as01","article-title":"Standards of medical care in diabetes-2021 Abridged for primary care providers","volume":"39","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. Standards of medical care in diabetes-2021 Abridged for primary care providers. Clin Diabetes. 2021, 39:14-43. 10.2337\/cd21-as01","journal-title":"Clin Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S013","article-title":"13. Older adults: Standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older adults: Standards of medical care in diabetes-2022. Diabetes Care. 2022, 45:S195-207. 10.2337\/dc22-S013","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000031","article-title":"Cognitive impairment in older adults and therapeutic strategies","volume":"73","author":"Montine TJ","year":"2021","unstructured":"Montine TJ, Bukhari SA, White LR. Cognitive impairment in older adults and therapeutic strategies. Pharmacol Rev. 2021, 73:152-62. 10.1124\/pharmrev.120.000031","journal-title":"Pharmacol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14603","article-title":"Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review","volume":"24","author":"Evans M","year":"2022","unstructured":"Evans M, Engberg S, Faurby M, Fernandes JD, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2022, 24:377-90. 10.1111\/dom.14603","journal-title":"Diabetes Obes Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al.. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016, 375:311-22. 10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al.. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016, 375:1834-44. 10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-28. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1712572","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Rajagopalan S","year":"2017","unstructured":"Rajagopalan S, Brook R. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017, 377:2098-9. 10.1056\/NEJMc1712572","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink HJ","year":"2020","unstructured":"Heerspink HJ, Stef\u00e1nsson BV, Correa-Rotter R, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020, 383:1436-46. 10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic V","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, et al.. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019, 380:2295-306. 10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes-2025. Diabetes Care. 2025, 48:S181-206. 10.2337\/dc25-S009","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1273","article-title":"Impact of persistent medication adherence and compliance with lifestyle recommendations on major cardiovascular events and one-year mortality in patients with type 2 diabetes and advanced stages of atherosclerosis: Results from a prospective cohort study","volume":"18","author":"Shalaeva EV","year":"2023","unstructured":"Shalaeva EV, Bano A, Kasimov U, Janabaev B, Laimer M, Saner H. Impact of persistent medication adherence and compliance with lifestyle recommendations on major cardiovascular events and one-year mortality in patients with type 2 diabetes and advanced stages of atherosclerosis: Results from a prospective cohort study. Glob Heart. 2023, 18:61. 10.5334\/gh.1273","journal-title":"Glob Heart"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109108","article-title":"Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding","volume":"62","author":"DeFronzo RA","year":"1978","unstructured":"DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest. 1978, 62:204-13. 10.1172\/JCI109108","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0314-4","article-title":"Increasing incidence of diagnosed type 2 diabetes in Taiwan: Analysis of data from a national cohort","volume":"49","author":"Tseng CH","year":"2006","unstructured":"Tseng CH, Tseng CP, Chong CK, et al.. Increasing incidence of diagnosed type 2 diabetes in Taiwan: Analysis of data from a national cohort. Diabetologia. 2006, 49:1755-60. 10.1007\/s00125-006-0314-4","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman RR","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008, 359:1577-89. 10.1056\/NEJMoa0806470","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1093","article-title":"Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Advances and contributions","volume":"62","author":"Nathan DM","year":"2013","unstructured":"Nathan DM, Bayless M, Cleary P, et al.. Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Advances and contributions. Diabetes. 2013, 62:3976-86. 10.2337\/db13-1093","journal-title":"Diabetes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0807625","article-title":"UKPDS and the legacy effect","volume":"359","author":"Chalmers J","year":"2008","unstructured":"Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med. 2008, 359:1618-20. 10.1056\/NEJMe0807625","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial","volume":"371","author":"Weng J","year":"2008","unstructured":"Weng J, Li Y, Xu W, et al.. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial. Lancet. 2008, 371:1753-60. 10.1016\/S0140-6736(08)60762-X","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2004.04.013","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"88","author":"DeFronzo RA","year":"2004","unstructured":"DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004, 88:787-835, ix. 10.1016\/j.mcna.2004.04.013","journal-title":"Med Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: There has to be a primary functional abnormality","volume":"52","author":"Kahn SE","year":"2009","unstructured":"Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: There has to be a primary functional abnormality. Diabetologia. 2009, 52:1003-12. 10.1007\/s00125-009-1321-z","journal-title":"Diabetologia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404750-association-of-antidiabetic-medication-regimens-and-medication-adherence-with-hba1c-reduction-in-type-2-diabetic-patients-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:35:49Z","timestamp":1758472549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404750-association-of-antidiabetic-medication-regimens-and-medication-adherence-with-hba1c-reduction-in-type-2-diabetic-patients-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,21]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.92853","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,21]]}}}